Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S80-4. doi: 10.1097/MCG.0b013e318169c44e.

Probiotics and liver disease.

Author information

  • 1Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT 06520-8000, USA.

Abstract

Modulation of intestinal flora through the use of probiotics is an emerging therapeutic strategy in the management of chronic liver diseases. This article focuses on the pathophysiologic basis for using probiotics in liver disease and reviews the existing literature on the subject. The role of probiotics is examined in the following areas: a) prevention of infection, b) the hyperdynamic circulatory state of cirrhosis, c) hepatic encephalopathy, d) liver function, and e) nonalcoholic fatty liver disease.

PMID:
18542037
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk